05:22 PM EDT, 10/29/2025 (MT Newswires) -- Nello Mainolfi, Director, Chief Executive Officer, on October 29, 2025, sold 30,000 shares in Kymera Therapeutics ( KYMR ) for $1,829,737. Following the Form 4 filing with the SEC, Mainolfi has control over a total of 660,482 common shares of the company, with 660,482 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1815442/000119312525256673/xslF345X05/ownership.xml